Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
about
Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay ValidationEffective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D).Progress in immune-based therapies for type 1 diabetes.
P2860
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@ast
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@en
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@nl
type
label
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@ast
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@en
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@nl
prefLabel
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@ast
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@en
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@nl
P2093
P2860
P356
P1476
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes
@en
P2093
P2860
P304
P356
10.1111/CEI.12063
P407
P577
2013-05-01T00:00:00Z